Pure red cell aplasia: its clinical association and treatment.
Wong
K F
KF
Kwong
Y L
YL
D002869:Chromosome Aberrations; D002999:Clone Cells / Q000473:pathology; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D016572:Cyclosporine / Q000009:adverse effects / Q000627:therapeutic use; D018450:Disease Progression; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000209:etiology* / Q000235:genetics / Q000473:pathology; D011289:Preleukemia / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics / Q000473:pathology; D012010:Red-Cell Aplasia, Pure / Q000188:drug therapy / Q000208:ethnology / Q000235:genetics / Q000473:pathology; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003520:Cyclophosphamide